AKUMS DRUGS Q2 FY27 ; NET PROFIT UP 168% AT ₹115 CR (YOY), UP 13% (QOQ)

REVENUE UP 32% AT ₹1,342 CR (YOY), UP 15% (QOQ) EBITDA UP 106% AT ₹195 CR (YOY), UP 11% (QOQ) MARGINS AT 14.5% VS 9.3% (YOY), 15.0% (QOQ)

AKUMS DRUGS AND PHARMA L